Corcept Therapeutics Incorporated Contracts & Agreements

Tenth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of May 13, 2024 (Filed With SEC on July 29, 2024)

th Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of (Filed With SEC on May 1, 2024)

Third Amendment to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, effective as of April 1, 2024 (Filed With SEC on May 1, 2024)

Sublease by and between Zuora, Inc. and Corcept Therapeutics Incorporated, entered into as of April 12, 2024 (Filed With SEC on May 1, 2024)

Corcept Therapeutics Incorporated Insider Trading Policy (Filed With SEC on February 15, 2024)

Form of 2012 Incentive Award Plan Restricted Stock Unit Grant Notice and Agreement (Filed With SEC on August 2, 2023)

Form of 2012 Incentive Award Plan Restricted Stock Award Grant Notice and Agreement (Filed With SEC on August 2, 2023)

Eighth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of April 1, 2023 (Filed With SEC on May 3, 2023)

Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Filed With SEC on November 3, 2022)

Task Order Number One to Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Filed With SEC on November 3, 2022)

Amendment to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, made and entered into as of August 1, 2022 (Filed With SEC on November 3, 2022)

Amendment No. 2 to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, made and entered into as of September 16, 2022 (Filed With SEC on November 3, 2022)

Form of 2012 Incentive Award Plan Restricted Stock Unit Grant Notice and Agreement (Filed With SEC on August 4, 2022)

Form of 2012 Incentive Award Plan Restricted Stock Award Grant Notice and Agreement (Filed With SEC on August 4, 2022)

Employment offer letter to William Guyer, dated July 2, 2021 (Filed With SEC on February 15, 2022)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and William Guyer, dated February 9, 2022 (Filed With SEC on February 15, 2022)

Form of 2012 Incentive Award Plan Stock Option Grant Notice and Agreement (Filed With SEC on February 15, 2022)

Separation Agreement by and between Corcept Therapeutics Incorporated and Andreas Grauer, M.D., dated August 11, 2021 (Filed With SEC on August 13, 2021)

Offer of Employment to Atabak Mokari, dated March 1, 2021 (incorporated by reference to Exhibit 10.1 to the registrant's Form 8-K filed on March 1, 2021) (Filed With SEC on May 6, 2021)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Atabak Mokari, dated March 1, 2021 (incorporated by reference to Exhibit 10.2 to the... (Filed With SEC on May 6, 2021)

Employment Offer Letter to Atabak Mokari, dated December 21, 2020 (Filed With SEC on March 1, 2021)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Atabak Mokari, dated March 1, 2021 (Filed With SEC on March 1, 2021)

Description of Common Stock (Filed With SEC on February 23, 2021)

Sixth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of July Sixth Amendment to Office... (Filed With SEC on November 3, 2020)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Hazel Hunt, dated August 3, 2020 (Filed With SEC on August 4, 2020)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Joseph Douglas Lyon, dated August 3, 2020 (Filed With SEC on August 4, 2020)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Sean Maduck, dated August 3, 2020 (Filed With SEC on August 4, 2020)

Fifth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of June 17, 2020 (Filed With SEC on August 4, 2020)

Description of Common Stock (Filed With SEC on February 24, 2020)

First Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of June 1, 2017 (Filed With SEC on February 24, 2020)

Second Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of March 12, 2018 (Filed With SEC on February 24, 2020)

Third Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of November 8, 2018 (Filed With SEC on February 24, 2020)

Fourth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of October 23, 2019 (Filed With SEC on February 24, 2020)

Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, effective as of April 1, 2016 (Filed With SEC on February 24, 2020)

Severance and Change in Control Agreement by and between Corcept Therapeutics Incorporated and Andreas Grauer, M.D., dated March 18, 2019 (Filed With SEC on May 9, 2019)

Employment offer letter to Andreas Grauer, M.D. dated March 18, 2019 (Filed With SEC on May 9, 2019)

Amendment N1 to the Manufacturing and Supply Agreement effective 19 March 2014 with PCAS SA, dated July 25, 2018 (Filed With SEC on February 26, 2019)

Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Filed With SEC on November 3, 2017)

Task Order Number One to Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Filed With SEC on November 3, 2017)

CORCEPT THERAPEUTICS INCORPORATED CONSULTING AGREEMENT (Filed With SEC on November 6, 2015)

149 Commonwealth Drive. Menlo Park, CA 94025 .Tel ###-###-#### .Fax ###-###-#### (Filed With SEC on November 6, 2015)

SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on November 6, 2015)

SECOND AMENDMENT TO PHARMACEUTICAL MANUFACTURER SERVICES AGREEMENT (Filed With SEC on March 13, 2015)

THIRD AMENDMENT TO COMMERCIAL OUTSOURCING SERVICES AGREEMENT (Filed With SEC on November 7, 2014)

FIRST AMENDMENT TO COMMERCIAL OUTSOURCING SERVICES AGREEMENT (Filed With SEC on August 8, 2014)

COMMERCIAL MANUFACTURING AGREEMENT (Filed With SEC on August 8, 2014)

SECOND AMENDMENT TO COMMERCIAL OUTSOURCING SERVICES AGREEMENT (Filed With SEC on August 8, 2014)

CORCEPT THERAPEUTICS INCORPORATED CONSULTING AGREEMENT (Filed With SEC on May 12, 2014)

September 5, 2012 Manufacturing and Supply Agreement (Filed With SEC on May 12, 2014)

Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park, CA 94025 (Filed With SEC on March 14, 2014)

Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park, CA 94025 (Filed With SEC on November 12, 2013)

PHARMACEUTICAL MANUFACTURER SERVICES AGREEMENT (Filed With SEC on August 9, 2013)

Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park, CA 94025 (Filed With SEC on August 9, 2013)

AMENDMENT TO PHARMACEUTICAL MANUFACTURER SERVICES AGREEMENT (Filed With SEC on August 9, 2013)

Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park, CA 94025 (Filed With SEC on August 9, 2013)

Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park, CA 94025 (Filed With SEC on March 15, 2013)

COMMERCIAL OUTSOURCING SERVICES AGREEMENT (Filed With SEC on August 9, 2012)

AMENDED AND RESTATED EXCLUSIVE PHARMACY PRODUCT PURCHASE ANDSERVICE AGREEMENT (Filed With SEC on August 9, 2012)

AMENDED AND RESTATED EXCLUSIVE WHOLESALE PRODUCT PURCHASE AGREEMENT (Filed With SEC on August 9, 2012)

11,000,000 Shares CORCEPT THERAPEUTICS INCORPORATED Common Stock ($0.001 par value) UNDERWRITING AGREEMENT (Filed With SEC on July 6, 2012)

MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on May 10, 2012)

Manufacturing and Supply Agreement (Filed With SEC on May 10, 2012)

Form of Warrant (Filed With SEC on March 29, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 29, 2012)

CORCEPT THERAPEUTICS INCORPORATED WARRANT PURCHASE AGREEMENT (Filed With SEC on March 29, 2012)

SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on November 8, 2011)

Corcept Therapeutics Incorporated 2004 Equity Incentive Plan Stock Option Grant Notice and Agreement (Filed With SEC on March 15, 2011)

DEVELOPMENT AGREEMENT BY AND BETWEEN CORCEPT THERAPEUTICS AND FORMULATION TECHNOLOGIES L.L.C. DATED AS OF December 14, 2006 (Filed With SEC on March 15, 2011)

MASTER SERVICES AGREEMENT (Filed With SEC on March 15, 2011)

Corcept Therapeutics Incorporated 10,000,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on January 21, 2011)

SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on November 12, 2010)

Corcept Therapeutics Incorporated 5,000,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on June 25, 2010)

Form of Warrant (Filed With SEC on April 23, 2010)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 23, 2010)

CORCEPT THERAPEUTICS INCORPORATED WARRANT PURCHASE AGREEMENT (Filed With SEC on April 23, 2010)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF CORCEPT THERAPEUTICS INCORPORATED (Filed With SEC on November 12, 2009)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 12, 2009)

CORCEPT THERAPEUTICS INCORPORATED SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 12, 2009)

AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 31, 2009)

AMENDMENT TO REGISTRATION RIGHTS AGREEMENT November 11, 2008 (Filed With SEC on March 31, 2009)

SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 31, 2009)

SECOND AMENDMENT (Filed With SEC on November 14, 2008)

MASTER SERVICES AGREEMENT (Filed With SEC on August 14, 2008)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF CORCEPT THERAPEUTICS INCORPORATED (Filed With SEC on March 31, 2008)

WARRANT (Filed With SEC on March 31, 2008)

CORCEPT THERAPEUTICS INCORPORATED SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 31, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 31, 2008)

byand between KINGSBRIDGE CAPITAL LIMITED and CORCEPT THERAPEUTICS INCORPORATED (Filed With SEC on March 31, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 31, 2008)

INDEMNIFICATION AGREEMENT (Filed With SEC on November 14, 2007)

Common Stock Purchase Agreement, dated as of August 16, 2007 (Filed With SEC on August 21, 2007)

SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on August 14, 2007)

Common Stock Purchase Agreement dated as of March 30, 2007 (Filed With SEC on April 3, 2007)

Manufacturing and Supply Agreement (Filed With SEC on April 2, 2007)

CORCEPT THERAPEUTICS INCORPORATED COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on November 16, 2006)

See Note 1 (Filed With SEC on August 11, 2005)

reluctance on the part of patients with PMD to accurately report their psychotic symptoms (Filed With SEC on March 29, 2005)

OF CORCEPT THERAPEUTICS, INC. (Filed With SEC on April 9, 2004)

Shares CORCEPT THERAPEUTICS INCORPORATED COMMON STOCK (Filed With SEC on March 19, 2004)

AMENDED ANDRESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 19, 2004)

OF CORCEPT THERAPEUTICS, INC. (Filed With SEC on March 19, 2004)

MASTER SERVICES AGREEMENT (Filed With SEC on March 19, 2004)

SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTEDPORTIONS RESEARCH AGREEMENT/ cGMP MANUFACTURING (Filed With SEC on February 10, 2004)

Category

Industry

Companies

Contracts

Corcept Therapeutics Incorporated Contracts & Agreements